Condition: Treatment Resistant Depression · Sponsor: University Hospital, Ghent
The purpose of this study is to determine the safety and feasibility of performing psilocybin-assisted psychotherapy in patients hospitalized for treatment-resistant depression.
This description comes directly from the study's public registry record.
Cisse Geleyn, dr. · 003293328742 · cisse.geleyn@uzgent.be
Always discuss trial participation with your own doctor first.
| Ghent University Hospital | Ghent, Oost-Vlaanderen, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06378229